A Study on Dong Scheduling Using HIV Dynamics and Optimal Control
![]() |
허영희
((주)삼성전자 DM사업부)
고지현 (한양대학교 전자전기컴퓨) 김진영 (한양대학교 전자전기컴퓨) 남상원 (한양대학교 전자전기컴퓨) 심형보 (서울대학교 전기공학) 정정주 (한양대학교 전자전기컴퓨터) |
1 | D. Wodarz and D. C. Krakauer, 'Defining CTL-induced pathology : implications for HIV,' Virology, vol. 274, pp. 94-104, August 2000 DOI ScienceOn |
2 | R. B. Moss, F. C. Jensen and D. J. Carlo, 'Insights into HIV-specific immune function: implications for therapy and prevention in the new millennium,' Clin. Immunol., vol. 95, pp. 79-84, May 2000 DOI ScienceOn |
3 |
J. A. Aberg et. al. 'HIV insite knowledge base,' |
4 |
J. A. Sullivan, 'Human Immunodeficiency Virus(HIV): overview,' |
5 | D. Wodarz and M. A. Nowak, 'Specific therapy regimes could lead to long-term immunological control of HIV,' PNAS, vol. 96, pp. 14464-14469, December 1999 DOI |
6 | D. Wodarz and V. A. A. Jansen, 'The role of T cell help for anti-viral CTL resonses,' J. theor. Biol., vol. 211, pp. 419-432, May 2001 DOI ScienceOn |
7 | R. F. Stengel, R. Ghigliazza and N. Kulkarni, 'Optimal enhancement of immune response,' Bioinformatics, vol. 18, pp. 1227-1235, March 2002 DOI ScienceOn |
8 | R. F. Stengel, R. Ghigliazza, N. Kulkarni and O. Laplace, 'Optimal control of innate immune response,' Optical Control Applications and Methods, vol. 23, pp. 91-104, January 2002 DOI ScienceOn |
9 |
D. Pieribone, 'The HIV life cycle,' |
10 | C. A. Janeway, 'Immunobiology,' Garland Churchill Living-stone, 2001 |
11 | D. Wodarz, 'Helper-dependent vs. helper-independent CTL responses in HIT infection: implications for drug therapy and resistance,' J. Theor. Biol., vol. 213, pp. 447-459, August 2001 DOI ScienceOn |
12 | J. A. M. Felippe de Souza, M. A. L. Caetano and T. Yoneyama, 'Analysis of a sub-optimal scheme of drug dosage in the AIDS treatment,' In proceedings of American Control Conference, pp. 1188-1193, Denber, Colorado, June 2003 DOI |
13 | D. Wodarz and M. A. Nowak, 'Mathematical models of HIV pathogenesis and treatment,' Bioessays, vol. 24, pp. 1178-1187, 2002 DOI ScienceOn |
14 | H. Shim, S. J. Han, C. C. Chung, S. W. Nam and J. H. Seo, 'Optimal scheduling of drug treatment for HIV infection: continuous dose control and receding horizon control,' To appear in International Journal of Control, Automation and Systems, vol. 1, no. 3, September 2003 |
15 | Y. T. Yang, P. W. Lee, K. W. Choi, K. H. Kim, and M. J. Kim, 'AIDS : 본체, 현황 및 대책,' 1988 |
16 | R. Zurakowski and A. R. Teel, 'Enhancing immune response to HIV infection using MPC-based treatment scheduling,' In proceedings of American Control Conference, Denber, June 2003 DOI |
17 | M. E. Brandt and G. Chen, 'Feedback control of a biodynamical model of HIV-1,' IEEE Trans. on biomedical Engineering, vol. 48, pp. 754-759, July 2001 DOI ScienceOn |
18 | R. F. Stengel, R. Ghigliazza, N. Kulkarni and O. laplace, 'Optimal control of a viral disease,' In proceedings of American Control Conference, vol. 5, pp.3795-3800, June 2001 DOI |
19 | J. A. M. Felippe de Souza, M. A. L. Caetano and T. Yoneyama, 'Optimal control theory applied to the anti-viral treatment of AIDS,' In proceedings of Conference on Decision and Control, pp. 4839-4844, Sydney, December 2000 DOI |
20 | J. J. Kutch and P. Gurfil, 'Optimal control of HIV infection with acontinuously-mutating viral population,' Proceedings of the American Control Conference, pp. 4033-4038, Anchorage, May 2002 DOI |
21 |
F. Hoffmann-La Roche Ltd, 'What is HIV?,' |
22 | D. Wodarz and M. A. Nowak, 'CD8 memory, immunodominance, and antigenic escape,' Eur. J. Immunol., vol. 30, pp. 2704-2712, September 2000 DOI ScienceOn |
23 |
National Institute of Allergy and Infectious Diseases, 'How HIV causes AIDS,' |
![]() |